Auxilium Pharmaceuticals Inc.
40 Valley Stream Parkway
Malvern,
PA 19355
United States - Map
Phone: 484-321-5900
Fax: 484-321-5999
Website: http://www.auxilium.com
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, engages in developing and marketing pharmaceutical products primarily in the United States. It markets Testim, a testosterone gel for the treatment of hypogonadism; and XIAFLEX (collagenase clostridium histolyticum), an injectable collagenase enzyme for the treatment of Dupuytrens contracture in adult patients with a palpable cord. The company is also developing XIAFLEX, which is in Phase III clinical trial for the treatment of Peyronies disease, in Phase IIa clinical trial for the treatment of Adhesive Capsulitis (frozen shoulder syndrome), and in Phase Ib clinical trial for the treatment of edematous fibrosclerotic panniculopathy indications. In addition, it has rights to pursue various other indications for XIAFLEX. The company sells its products to wholesale drug distributors, specialty pharmacies, specialty distributors, and chain drug stores. Auxilium Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Malvern, Pennsylvania. Key Statistics
| |
| Auxilium Pharmaceuticals Inc.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (Low Concern), Compensation (High Concern), Shareholder Rights (Medium Concern). | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Adrian Adams ,
61
Chief Exec. Officer, Pres and Director | 20.00K | 0.00 | Mr. James E. Fickenscher ,
48
Chief Financial Officer and Principal Accounting Officer | 508.00K | 0.00 | Mr. Alan J. Wills ,
49
Exec. VP of Corp. Devel. | 480.00K | 0.00 | Ms. Nancy S. Lurker ,
54
Director and Member of Nominating & Corp. Governance Committee | 0.00 | N/A | Dr. Benjamin J. Del Tito Jr.,
56
Exec. VP of Regulatory Affairs and Project Management | N/A | N/A |
|
| | Amounts are as of Dec 30, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.60% Nasdaq 
0.16(0.86%) May 25, 4:00PM EDT|After Hours:
19.28